Correction to “Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours”
{"title":"Correction to “Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours”","authors":"","doi":"10.1002/bco2.70071","DOIUrl":null,"url":null,"abstract":"<p>Aziz NA, Ng K, Alifrangis C, Tran B, Conduit C, Liow E, et al. <b>Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours</b>. BJUI Compass. 2025; 6(8):e70057. https://doi.org/10.1002/bco2.70057.</p><p>In the originally published article, Section 3.2—<i>Secondary Objectives and Endpoints—</i>was not presented in the correct sequence. While the content is factually accurate, the structure is disordered and several objectives are repeated or misaligned, which may confuse readers. The correct version appears below.</p><p><b>3.2 | Secondary objectives and endpoints</b></p><p>We apologize for this error.</p>","PeriodicalId":72420,"journal":{"name":"BJUI compass","volume":"6 9","pages":""},"PeriodicalIF":1.9000,"publicationDate":"2025-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://bjui-journals.onlinelibrary.wiley.com/doi/epdf/10.1002/bco2.70071","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJUI compass","FirstCategoryId":"1085","ListUrlMain":"https://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.70071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aziz NA, Ng K, Alifrangis C, Tran B, Conduit C, Liow E, et al. Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours. BJUI Compass. 2025; 6(8):e70057. https://doi.org/10.1002/bco2.70057.
In the originally published article, Section 3.2—Secondary Objectives and Endpoints—was not presented in the correct sequence. While the content is factually accurate, the structure is disordered and several objectives are repeated or misaligned, which may confuse readers. The correct version appears below.